Since 1993, the AACR has awarded more than $542 million in grants to fund meritorious research projects across the spectrum of cancer science, including basic, translational, and clinical research. See how the AACR grants program has contributed to the AACR's mission.
Chemotherapy-induced cognitive impairment (CICI), also known as chemobrain, can affect up to 75% of patients during treatment. Recipient of the 2019 The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine Alfredo Oliveros, PhD, and his colleagues showed that inhibiting adenosine A2A receptor signaling can prevent cisplatin-induced cognitive impairment.
By Christina Leah B. Kline, PhD Participating at the biggest cancer meeting in the world from the comforts of your lab desk or your home has its perks. Yet, the 2022 AACR Annual Meeting proved that meeting colleagues face...
The AACR-Genentech BioOncology Career Development Award for Cancer Research on the HER Family Pathway encouraged and supported a physician-scientist to conduct cancer research on the HER Family Pathway and to establish a successful career path in this field. Christine...
The AACR-CRUK Transatlantic Fellowships support promising postdoctoral cancer researchers at US and UK research institutions to carry out a portion of their postdoctoral research at a research institution in the UK or the US, respectively. The AACR-CRUK fellows share the impact of this unique program on their careers and research.
In the midst of the excitement surrounding CAR T therapies, much needs to be done to optimize CAR T cell efficacy. 2017 AACR Next Gen Grant Recipient Sidi Chen, PhD leveraged in vivo genome engineering methods and identified a new target to do just that.
Michele Carbone, MD, PhD, investigated an epidemic of mesothelioma in remote villages in Turkey and discovered a new cancer syndrome caused by an inherited anomaly. An AACR grant supported his research.
The AACR-Conquer Cancer Foundation (CCF) of ASCO Young Investigator Award for Translational Cancer Research funds a physician-scientist during the transition from a fellowship program to a faculty appointment. 2020 Recipient Dr. Mathios speaks on the grant's impact on his research and career.
The 2020 AACR-The Mark Foundation for Cancer Research “Science of the Patient” SOP Grants Program seeks to stimulate novel research on the interplay between patient physiology and the tumor. The five grantees have been conducting breakthrough research -- studying cancer not as an isolated phenomenon but as a systemic disease.
Sarah Bohndiek, PhD, of the University of Cambridge. once thought she wanted to be an astrophysicist. She trained instead in radiation physics, and a grant from the AACR and Amgen helped her move into molecular imaging and early detection of cancer.
A grant from the AACR in 2000 helped Karlyne Reilly, PhD, launch her career in cancer research. She is now head of the Rare Tumor Initiative at the National Cancer Institute and works to involve scientists, patients, family members, advocates, and healthcare providers in the search for treatments for rare cancers.